Patent · US Expired

Compounds and methods for therapy and diagnosis of lung cancer

US6518256B1 · kind B1 · utility

6Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2000
Grant dateFeb 11, 2003
Priority date
Expiry dateApr 4, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds and methods for the treatment and diagnosis of lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.